Color Genomics' latest test highlights the quandary of genetic testing colliding with value-based care: Is the push to test taking preventive medicine in the wrong direction?
LabCorp (NYSE:LH) is set to acquire toxicology testing company MEDTOX Scientific (NASDAQ:MTOX) for $241 million as the laboratory testing and diagnostics firm builds out its specialty testing offerings. The definitive merger agreement calls for LabCorp to acquire MEDTOX for $27 per share in cash. That represents a 37 percent premium over MEDTOX’s $19.70 closing price […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
LabCorp (NYSE:LH) is partnering with molecular diagnostics firm XDx to develop a new diagnostic for lupus flares. Burlington, North Carolina-based LabCorp will work with XDx to develop a biomarker and commercialize a test for the flares — extended periods of activity for the autoimmune disease. Lupus causes the body’s immune system to attack its own […]
LabCorp (NYSE:LH) has struck a deal to develop and commercialize a new Alzheimer’s disease diagnostic. The Burlington, North Carolina lab services and diagnostics company has licensed rights to an Alzheimer’s diagnostic technology from OPKO Health (NYSE:OPK). The deal gives LabCorp exclusive rights to the OPKO technology in North America and the United Arab Emirates. No […]
LabCorp (NYSE:LH), after waiting eight months for regulators’ blessings, had a speedy wrap up of its $85 million acquisition of DNA testing company Orchid Cellmark. Laboratory testing and diagnostics firm LabCorp secured the greater than 90 percent of shares in Orchid that allowed the company to proceed with a short-form merger, meaning the deal could […]
LabCorp (NYSE:LH) has secured enough shares for its $85 million acquisition of DNA testing company Orchid Cellmark (NASDAQ:ORCH) but the company still wants more shares. Burlington, North Carolina-based LabCorp is extending its offer for the shareholders who did not tender their shares. The shares tendered represent 86.5 percent of Princeton, New Jersey-based Orchid’s outstanding shares, […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
LabCorp (NYSE:LH) finally has the regulatory go-ahead to complete its $85 million acquisition of DNA testing company Orchid Cellmark (NASDAQ:ORCH). The laboratory services and diagnostics firm said that it has reached an agreement with the U.S. Federal Trade Commission that calls for the company to sell off parts of Orchid’s U.S. government paternity business following […]
LabCorp (NYSE:LH) is under a federal probe investigating whether the laboratory services firm and others defrauded Medicare and Medicaid. The Senate inquiry comes months after a $49.5 million settlement with the state of California over claims that LabCorp overcharged California’s Medicaid program and gave doctors kickbacks for patient referrals. In a November 8 letter to […]
A new Roche (OTC:RHHBY) cancer drug expected to become a blockbuster could also end up being a boon for laboratory and diagnostics firm LabCorp (NYSE:LH). The Roche drug Zelboraf was approved in August by the Food and Drug Administration to treat melanoma patients whose advanced skin cancer cannot be removed by surgery. But Zelboraf works […]
LabCorp (NYSE:LH) will work with the David H. Murdock Research Institute to develop new testing tools that could be used in clinical research worldwide. Under the partnership with the DHMRI announced Wednesday, LabCorp’s clinical trials division, Esoterix, will provide the institute’s clients with access to test development services. New assays discovered and developed at DHMRI […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
LabCorp (NYSE:LH) is paying $49.5 million to settle a Medicaid fraud lawsuit claiming the company overcharged California’s Medicaid program and gave doctors medical kickbacks for patient referrals. Burlington, North Carolina-based LabCorp disclosed the proposed settlement payment in a securities filing. During today’s second quarter earnings conference call, LabCorp executives did not discuss the lawsuit or […]
LabCorp (NYSE:LH) needs a little more time to close its $85 million acquisition of Orchid Cellmark (NASDAQ:ORCH). The Burlington, North Carolina-based provider of laboratory services said Monday it has extended its offer for Orchid as it continues to work with the Federal Trade Commission to gain the regulator’s approval of the deal. LabCorp in April […]
LabCorp‘s (NYSE:LH) deadline to buy DNA testing services firm Orchid Cellmark (NASDAQ:ORCH) has been extended to July 15, the third extension for the deal in the last month. The Burlington, North Carolina-based diagnostics and laboratory services company in April had announced a definitive agreement to buy Orchid in a deal valued at more than $85 million. […]
Diagnostics technologies and lab services company LabCorp (NYSE:LH) is acquiring Clearstone Central Laboratories to boost the company’s capabilities and global reach providing services for clinical trials. Burlington, North Carolina-based LabCorp announced the definitive agreement on Wednesday, though the company did not disclose any financial terms of its proposed acquisition of privately held Clearstone. The companies […]